In a recent interview with PharmaShots, Peony Yu, Chief Medical Officer of FibroGen shared her insights and highlights on data of RoxadustatShots:FibroGen presented new efficacy and safety analyses from the…
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded…
In a recent interview with PharmaShots, Julie Foster, Vice President, Global Customer Experience of the Diabetes business at Medtronic, shares information about recent and upcoming announcements for the company.Shots:The integration…
In a recent interview with PharmaShots, Dr. Spetzler, President and Chief Scientific Officer of Caris Life Sciences shared his insights and highlights on the launch of CODEai.Shots:CODEai is…
In a recent interview with PharmaShots, Aidan Foley, Chairman and Chief Executive Officer of True Digital Surgery shared his insights and highlights on data of the Aesculap Aeos Robotic Digital Microscope.Shots:The robotic…
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop itLife sciences companies are putting all of their efforts…
Clinical studies cost money, time, and animal lives. There is an urgent need for alternative ways to model human diseases in-vitro to speed-up the new drug development process. Recently, Indian…
The US FDA has approved 4 NDAs and 1 BLA in Oct 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation…
In a recent interview with PharmaShots, Dr. Eiry Roberts, Chief Medical Officer of Neurocrine Biosciences shares her insights and highlights on data of Ongentys.Shots:In a post-hoc, sub-group analysis…
Healthy animals contribute to the elimination of hunger and sustainable food production. The diseases that affect animal health also affect humans. Tackling them while they are present in animals not…
